98 related articles for article (PubMed ID: 2741652)
1. A transient hemolytic reaction and stomatocytosis following vinca alkaloid administration.
Ohsaka A; Kano Y; Sakamoto S; Kanzaki A; Hashimoto M; Yawata Y; Miura Y
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):7-17. PubMed ID: 2741652
[TBL] [Abstract][Full Text] [Related]
2. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
[No Abstract] [Full Text] [Related]
3. Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
Kawada K; Ohta T; Fukuda H; Hayashi T; Tanaka K; Imai T; Morita Y; Miyamura M
Ann Hematol; 2020 Oct; 99(10):2429-2436. PubMed ID: 32839869
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphoma.
Takasugi BJ; Jones SE; Robertone AB
Cancer Treat Rep; 1984 Nov; 68(11):1399-401. PubMed ID: 6498855
[TBL] [Abstract][Full Text] [Related]
5. [Stomatocytosis with hemolysis presumably induced by vincristine administration in a patient with non-Hodgkin's lymphoma].
Ohsaka A; Tsuboyama A; Yoshida M; Kano Y; Sakamoto S; Miura Y; Shimoda M; Hashimoto M; Kanzaki A; Yawata Y
Rinsho Ketsueki; 1986 Jun; 27(6):891-7. PubMed ID: 3761576
[No Abstract] [Full Text] [Related]
6. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
7. [Five cases of hereditary high red cell membrane phosphatidylcholine hemolytic anemia in three families].
Wakita M; Matsui T; Tsuzuki M; Nomura T; Miyazaki H; Kojima H; Maruyama F; Okamoto M; Ino T; Ezaki K; Sugihara T; Kanzaki A; Yawata Y; Hirano M
Rinsho Ketsueki; 1996 Mar; 37(3):265-70. PubMed ID: 8727354
[TBL] [Abstract][Full Text] [Related]
8. [Microangiopathic hemolytic anemia in patients with diseases of the hematopoietic and lymphatic systems].
Paprocka E; Dwilewicz-Trojaczek J; Wieczorek J; Kuratowska Z
Pol Tyg Lek; 1989 Apr; 44(14):323-6. PubMed ID: 2622805
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-induced immune hemolytic anemia in a pediatric oncology patient presenting as an acute hemolytic transfusion reaction.
Gupta S; Piefer CL; Fueger JT; Johnson ST; Punzalan RC
Pediatr Blood Cancer; 2010 Dec; 55(6):1201-3. PubMed ID: 20589632
[TBL] [Abstract][Full Text] [Related]
10. [Hemolytic anemia in association with viral hepatitis].
Kanematsu T; Nomura T; Higashi K; Ito M
Nihon Rinsho; 1996 Sep; 54(9):2539-44. PubMed ID: 8890591
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in erythrocyte membrane ATPase activities evidenced by exposing the cells to different hemolytic solutions.
Finotti P; Verbaro R
Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):263-7. PubMed ID: 2526914
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic anemia.
Dhaliwal G; Cornett PA; Tierney LM
Am Fam Physician; 2004 Jun; 69(11):2599-606. PubMed ID: 15202694
[TBL] [Abstract][Full Text] [Related]
13. [Hereditary spherocytosis presenting with acute lymphoblastic leukemia].
Ishida Y; Niino M; Matsuda H; Bandou S
Rinsho Ketsueki; 1987 Mar; 28(3):402-7. PubMed ID: 3475487
[No Abstract] [Full Text] [Related]
14. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
Martin ME; Laber DA
Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of vinca alkaloids.
Rahmani R; Zhou XJ
Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
[TBL] [Abstract][Full Text] [Related]
16. [Hereditary stomatocytosis of the hydrocytosis type: a report of one family and red cell membrane studies].
Kida T; Nakamura H; Kuroki T; Mizoguchi Y; Kobayashi K; Yamane T; Im T; Tatsumi N; Ata K; Wada H
Rinsho Ketsueki; 1990 Jun; 31(6):813-9. PubMed ID: 2170705
[TBL] [Abstract][Full Text] [Related]
17. Vinca alkaloid-induced cardiovascular autonomic neuropathy.
Roca E; Bruera E; Politi PM; Barugel M; Cedaro L; Carraro S; Chacón RD
Cancer Treat Rep; 1985 Feb; 69(2):149-51. PubMed ID: 3971390
[TBL] [Abstract][Full Text] [Related]
18. Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia.
Ghosh S; Bandyopadhyay S; Bhattacharya DK; Mandal C
Ann Hematol; 2005 Feb; 84(2):76-84. PubMed ID: 15338196
[TBL] [Abstract][Full Text] [Related]
19. [Combination therapy of vinca alkaloids and nicardipine in non-Hodgkin's lymphoma with resistant to various antineoplastic agents].
Honda T; Sampi K; Hattori M
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2330-4. PubMed ID: 6639094
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
